Clinical Trial Update: Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed Phase 1 study evaluating the safety, tolerability, and preliminary activity of trabectedin combined with durva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• IMFINZI (DURVALUMAB)
• Yondelis (trabectedin)

Snippet

Sponsor: Institut Bergonié | Conditions: Ovarian Carcinoma, Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2025-09-04